BSE Live
Dec 10, 16:01Prev. Close
750.10
Open Price
755.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:53Prev. Close
752.85
Open Price
749.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
779.30 (141)
| Profit & Loss account of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 755.13 | 628.89 | 510.58 | 463.37 | 426.71 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 755.13 | 628.89 | 510.58 | 463.37 | 426.71 | |
| Total Operating Revenues | 759.88 | 630.96 | 513.08 | 465.93 | 427.60 | |
| Other Income | 17.65 | 13.47 | 9.97 | 6.71 | 3.09 | |
| Total Revenue | 777.52 | 644.42 | 523.05 | 472.64 | 430.70 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 493.38 | 386.59 | 340.71 | 307.56 | 270.74 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -21.52 | 9.59 | -15.27 | -4.74 | 3.67 | |
| Employee Benefit Expenses | 122.92 | 87.46 | 70.32 | 63.41 | 58.32 | |
| Finance Costs | 4.38 | 1.10 | 0.79 | 1.42 | 1.29 | |
| Depreciation And Amortisation Expenses | 27.99 | 13.44 | 12.36 | 12.15 | 12.97 | |
| Other Expenses | 70.99 | 69.22 | 57.07 | 46.81 | 40.18 | |
| Total Expenses | 698.13 | 567.40 | 465.99 | 426.60 | 387.17 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 79.39 | 77.02 | 57.06 | 46.04 | 43.53 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -32.35 | |
| Profit/Loss Before Tax | 79.39 | 77.02 | 57.06 | 46.04 | 11.18 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 18.27 | 17.34 | 14.35 | 10.13 | 4.84 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.47 | 1.54 | 0.06 | -2.66 | 1.33 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 18.75 | 18.88 | 14.41 | 7.48 | 6.17 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 60.65 | 58.14 | 42.64 | 38.56 | 5.01 | |
| Profit/Loss From Continuing Operations | 60.65 | 58.14 | 42.64 | 38.56 | 5.01 | |
| Profit/Loss For The Period | 60.65 | 58.14 | 42.64 | 38.56 | 5.01 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 29.03 | 27.95 | 19.71 | 18.81 | 2.75 | |
| Diluted EPS (Rs.) | 28.71 | 27.86 | 19.71 | 18.81 | 2.75 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 11.50 | 8.32 | 7.63 | 7.63 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 116.00 | 110.00 | 80.00 | 70.00 | 0.00 |
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y